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ABSTRACT
Chronic pain is a medical condition that severely
decreases the quality of life for those who struggle to
cope with it. Interactive voice response (IVR)
technology has the ability to track symptoms and
disease progression, to investigate the relationships
between symptom patterns and clinical outcomes, to
assess the efﬁcacy of ongoing treatments, and to
directly serve as an adjunct to therapeutic treatment for
chronic pain. While many approaches exist toward the
management of chronic pain, all have their pitfalls and
none work universally. Cognitive behavioral therapy
(CBT) is one approach that has been shown to be fairly
effective, and therapeutic interactive voice response
technology provides a convenient and easy-to-use
means of extending the therapeutic gains of CBT long
after patients have discontinued clinical visitations.
This review summarizes the advantages and
disadvantages of IVR technology, provides evidence for
the efﬁcacy of the method in monitoring and managing
chronic pain, and addresses potential future directions
that the technology may take as a therapeutic
intervention in its own right.
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INTRODUCTION
During the past two decades, there has been
considerable growth in the use of computer-medi-
ated technologies for assessment and treatment.
One such technology is interactive voice response
(IVR), an automated telephone-based interface that
provides patients and research subjects with direct
access to pre-recorded questionnaires, educational
materials, custom messages, and even therapeutic
assistance [1]. Typically, patients or research sub-
jects are provided with a phone number to connect
to a computer database interface that provides high-
quality pre-recorded interactions. Using a branched
logic format, IVR menus are navigated and ques-
tions are answered by pressing speciﬁc buttons on a
touch-tone keypad that correspond to different
options or responses. These selections are then
stored for later analysis. Additionally, some IVR
systems provide patients and subjects with the
ability to record their own verbal responses to
open-ended questions. Many modern applications
of IVR now utilize voice recognition software rather
than touch-tone responding for increased conve-
nience. The continued success of IVR as a clinical
and research method is due in part to improve-
ments in voice recognition software and in part to
development of open-standard IVR platforms such
as the World Wide Web Consortium’s Voice
Extensible Markup Language and the Speech
Application Language Tags Forum [2]. There are
also several companies (e.g., TeleSage, Chapel Hill,
NC and DirectConnect, Omaha, NE) that provide
access to established IVR systems.
Some of the simplest and most common applica-
tions of IVR to clinical research are participant
screening, study enrollment, and group randomiza-
tion [3, 4]. Computer algorithms can be used to
analyze subjects’ responses to demographic ques-
tions (e.g., age and gender) in order to determine
study eligibility and to randomly assign participants
to different experimental conditions. Some other
established applications of IVR include survey/
questionnaire administration [5–7]; tracking of
medication adherence [8, 9]; smoking cessation
education and counseling [10, 11]; alcohol and
substance abuse withdrawal and relapse tracking
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Implications
Researchers: this detailed review of the litera-
ture will give broad information about the use of
telephone-based technology in clinical research.
Practitioners: this review of the literature will
give practitioners information on how the
telephone-based technology can help patients
with chronic pain to prevent relapse into pain
behavior.
Policymakers: this review of the literature may
help policymakers in making decisions regarding
insurance coverage for computerized treatments.
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[12–15]; monitoring of drinking [16–19], smoking
[20], and binge eating behaviors [21]; screening for
and monitoring symptoms of depression [22–25],
anxiety [23], and OCD [26, 27]; reporting on the
efﬁcacy and side effects of pharmaceutical regi-
mens [9, 25, 28]; symptom monitoring in cardiac
patients [29]; and psychological performance
assessment [30].
In addition to passively using IVR to monitor
ongoing medical conditions, IVR is also applied as
an adjunct to medical treatment. For example, IVR
has been employed to assist with weight loss and
cholesterol management [31], to facilitate healthier
lifestyles in a pre-diabetic population [32], to help
monitor and improve glucose levels in patients with
diabetes [33], to teach and facilitate stress manage-
ment techniques [34], to improve patient safety after
hospital discharge [35], to provide brief intervention
for alcohol abuse [13, 36–38], to assist with smoking
cessation [39], and for clinical interventions such as
self-administered psychotherapy for depression [40]
and relapse prevention following cognitive behavioral
therapy (CBT) for alcohol use [41].
IVR has proved to be an extremely effective tool
in the study of chronic pain, as well. Most patients
with chronic pain experience periods of ﬂuctuating
symptom severity. Due to this variability, IVR can
be a powerful monitoring tool in that patients are
able to report symptom severity on an hourly, daily,
weekly, or real-time event-contingent basis, allowing
clinicians and researchers to control or, if utilized in
a properly designed study, eliminate the inﬂuence of
recall bias on perception of symptom severity. IVR
is also useful for keeping track of medication need
and adherence, efﬁcacy and adverse side effects of
medications, and effectiveness of ongoing therapeutic
regimens. Overall, it has been clearly demonstrated
that inclusion of IVR in chronic disease management
has the potential to improve clinical outcomes while
decreasing treatment-associated costs [42, 43]. This
review will focus speciﬁcally on applications of
IVR to the study and treatment of chronic pain,
though its applicability to the study and treatment of
other psychological disorders is also suggested by the
current literature.
ADVANTAGES OF IVR IN CLINICAL RESEARCH
The major appeals of using IVR in clinical research
are its convenience of remote access, high level of
accessibility, and cost-effectiveness [44]. Telephones
are simple to use and familiar to people of most
demographics, an advantage of IVR over some of
the similar internet-based approaches that are also
currently being employed. IVR systems are avail-
able 24 h per day, are accessible by multiple patients
at the same time, can utilize different languages for
survey administration, and are capable of reaching
broad populations. IVR is easier to access than in-
person interviews for populations with socioeco-
nomic concerns that may rule out easy computer
access, might have difﬁculty with the unfamiliarity
of computer-based approaches, or live too far away
to realistically visit the research center on a regular
basis. IVR systems can also be used to initiate
calls, text messages, or even emails to act as
reminders for those who have not called in by a
certain prearranged time.
Unlike traditional telephone interviews and writ-
ten questionnaires, IVR systems are capable of
collecting information and immediately storing it
in a computer database without the need for
labor-intensive clinician or researcher involve-
ment [45], even for extremely large numbers of
study participants. Research has demonstrated
that IVR interviews are as valid as in-person
written questionnaires, live telephone interviews,
and internet-based approaches when using meas-
ures such as symptom-quantifying questionnaires
[6, 7, 12, 45–49].
One of the few difference observed between
symptom reporting via IVR and in-person inter-
views is that some groups of subjects report an
increased sense of anonymity that allows them to
honestly disclose sensitive information to an auto-
mated system that they might be too embarrassed or
otherwise unwilling to discuss face-to-face or via a
written questionnaire [2, 12, 23, 50–53]. For
example, studies show that subjects report higher
levels of drug and alcohol abuse when using IVR
as compared to live interviews [18, 37, 49, 54].
Compared to in-person and live telephone sur-
veys, IVR ensures consistent phrasing, pacing, and
intonation of questions being asked, and negates any
interviewer bias that might otherwise exist [2]. IVR
can also present questionnaires to multiple partic-
ipants at the same time, does not depend on
participant literacy, and can utilize as many different
languages as are needed. Hundreds or thousands of
calls can be processed in a single day [55]. In
general, participants in IVR studies report that the
experience is both easy and convenient [27, 42, 56,
57]. Up to 85% of participants reported satisfaction
with using an IVR system, 82% believed that IVR
should accompany routine health care, 76% would
choose to receive automated calls in the future, and
only 16% were bothered by receiving automated
IVR calls/reminders [42, 43, 58].
Research has shown that levels of IVR compli-
ance tend to be relatively high. In two longitudinal
studies utilizing daily reporting, participants placed
calls more than two out of every 3 days when
reporting on the severity of pain symptoms and
medication usage [59], as well as to enhance brief
alcohol intervention (91% median call rate) [13]. In
one study, one fourth of diabetes patients completed
as many as 91% of daily calls [43]. In another
experiment, more than 80% of participants with
chronic pain completed 50% or more of daily calls
[60]. In a research setting, compliance can be further
improved by offering incentives for placing on-time
calls to the IVR system, or for consecutive daily/
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weekly calls. Combination of daily incentives with
bonuses for completing consecutive calls on all
7 days of a calendar week resulted in a total data
capture rate of 98.8% (93.8% on-time) [54]. Within a
population of recovering alcohol and drug users,
IVR compliance levels were higher than completion
rates for written daily questionnaires [12]. Daily pain
reporting using electronic diaries [61] appears to
have comparable levels of compliance (94%) to
IVR, as well. Unlike pencil-and-paper and electronic
diaries, however, IVR also has the ability to track
patient compliance in real time and bring compliance
concerns to the attention of researchers before they
become too severe [55].
One of the most useful advantages of IVR systems
is that they allow subjects to easily place reports in
an event-contingent, real-time basis (e.g., immedi-
ately after a change in symptom severity) or
according to a speciﬁc schedule, both of which have
advantages over reports placed retrospectively.
These momentary and daily assessments result in
more accurate reports than retrospective assess-
ments, possibly by reducing or eliminating recall
biases [61–66]. Possible explanations for this effect
are that patients might retrospectively fail to consid-
er pain-free periods when reporting average pain
levels [64], place disproportionate weight on peak or
more recent symptom experiences [67], employ
various cognitive heuristics, or even just have
difﬁculty remembering all pertinent events over
a longer reporting period [67]. A summary of
IVR’s advantages and disadvantages is presented
in Table 1.
DISADVANTAGES OF IVR IN CLINICAL RESEARCH
Some disadvantages of IVR in research include the
initial time and ﬁnancial commitments required to
write scripts, develop recordings, and acquire the
necessary hardware and software to run an IVR
system, as well to maintain equipment and back-up
data over time [50]. However, the up-front costs of
programming and hardware acquisition are ﬁxed
costs that can be spread out across an unlimited
number of participants. Alternatively, it is possible
to contract IVR setup and maintenance to one of
several companies that offer this service, but this
option represents a signiﬁcant ﬁnancial commit-
ment, as well. While the IVR hosting costs are not
ﬁxed, the incremental cost of adding new partic-
ipants is quite small. Whichever option is employed,
steps to prevent loss of data (e.g., due to computer
downtime, power outage, phone service interrup-
tion, etc.) must be taken. It is also imperative that
stored IVR data be maintained just as securely as
any other patient records.
Another major disadvantage of IVR is that some
participants of low socioeconomic status or who live
in remote regions may not have regular access to
telephone service. There is evidence that cellular
phone use is prevalent enough even in developing
countries [68] to support over-the-phone interven-
tions as viable models, but subjects who participate
in IVR studies using cellular phones run the risk of
poor reception and dropped calls. Most studies
address these concerns by utilizing toll-free phone
numbers that participants can use to access the IVR
system for free and allowing IVR computers to
pause a session when a call is disconnected, continuing
the session at the same location when the participant
reconnects.
While IVR compliance rates are high, they are
not perfect. Sophisticated statistical techniques such
as multi-level analyses [69, 70] are required for
interpretation of within-subject causal relationships
since the data tend to be highly correlated. If such
analyses are planned, studies should incorporate
reminder calls and incentives for compliance.
Although the available software can analyze data
with missing days, the underlying assumption is
Table 1 | Advantages and disadvantages of IVR in clinical research
Advantages Disadvantages
Easy 24/7 system access from most locations Unreliable telephone access in some areas
Cost-effectiveness Survey interruption due to dropped calls
Familiarity with telephone technology Not all instruments/surveys are validated for IVR
High level of compliance Inability to answer participant questions in real time
Increased perceived anonymity Inability of patients to seek clariﬁcation during survey
Ability to collect real-time momentary assessments Less personal than meeting with a clinician
More accurate than retrospective reporting Requires script validation, piloting, participant training
Consistency of survey administration Requires staff to program and maintain IVR system
Not dependent on patient literacy Costs associated with setup or commercial hosting
Not dependent on patient computer skills Limited to auditory presentation (lack of visuals)
Allows for a large numbers of participants
Allows simultaneous access to multiple patients
Efﬁcient data collection and storage
Efﬁcient tracking of recruitment and compliance
Inclusion of automated reminders
Table adapted from Abu-Hasaballah et al. [2]
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that behaviors are the same on non-reporting
days as on days when calls are made. Another
approach is to analyze “dyads,” or blocks of two
consecutive days upon which daily calls are
placed [70].
Another concern in IVR use for symptom mon-
itoring is reactivity: high-frequency reporting might
actually inﬂuence the severity of symptoms being
reported. For example, some concern exists that
frequent reporting of symptoms might result in
rumination/catastrophizing regarding those symp-
toms, thereby increasing their severity [63], though
other reports suggest that this is might not be the
case [61, 64]. The possibility of “stereotypic
responding,” or habitually responding in the same
manner rather than accurately assessing and report-
ing symptom states at the time of reporting, should
also be considered [63]. It must also be kept in mind
that the validity and effectiveness of only a limited
number of questionnaires, surveys, and therapeutic
approaches have been tested using IVR, to date.
Adaptation of new surveys to IVR systems may
require script validation and extensive piloting [2],
and it is possible that not all methods will maintain
validity when employed via IVR.
One proposed weakness of IVR is the lack of
personal interaction that comes with in-person inter-
views. Though this can actually be considered a
strength when collecting sensitive information about
socially unacceptable behaviors, depressed research
subjects reported a stronger ability to describe their
feelings during in-person interviews and rated
interview experiences with clinicians higher than
IVR [23]. While clinicians are able to tailor personal
feedback for individual patients using IVR, this may
not be as effective as using in-the-moment prompts
to delve deeper into issues as they arise. While many
IVR systems let patients listen to questions more
than once, they do not allow patients to seek
clariﬁcation regarding survey items or ask questions
of their own as they would do during an in-person
interview [2, 55]. Despite these disadvantages,
however, IVR could be an extremely useful and
cost-effective method for many experimental and
clinical approaches. Perhaps the most proven appli-
cation of IVR is for longitudinal tracking of
symptom progression in a regular, reliable manner.
IVR FOR SYMPTOM MONITORING IN CHRONIC PAIN
Most patients experience ﬂuctuations in pain sever-
ity that last hours, days, weeks, or months. IVR
technology allows patients to monitor and report the
severity of their symptoms as frequently as desired
or in real time on an event-contingent basis (e.g.,
when migraine symptoms begin). Daily data
concerning pain severity, negative affective compo-
nents of pain, and the deleterious effects of chronic
pain on day-to-day life can be monitored to create a
bigger picture of the progression of the disorder on a
short-term and longitudinal basis.
IVR has been utilized to track changes in the
severity of pain symptoms and treatment outcomes
in patients with both short-term [45] and chronic
pain [44, 71, 72]. The results of many questionnaires
that assess pain severity via IVR are not statistically
different from those obtained using traditional live
telephone interviews [45] and in-person evaluations
[47]. Validity of daily IVR reports has also been
compared to retrospective reports covering previous
1, 3, 7, and 28 days [67]. It has also been suggested
that, for chronic pain in particular, speciﬁc processes
that occur within a given day likely have stronger
effects on symptom severity than processes that
occur across multiple days [69, 73]. Retrospective
reports of pain severity tend to be higher than real-
time daily reports, suggesting that daily IVR report-
ing is more accurate than recalled ratings reported
retrospectively [67]. For example, daily reports of
pain severity averaged over the course of a week are
typically higher than weekly reports of pain severity
[55]. It has also been shown that IVR’s accuracy is
not entirely dependent on real-time, event-contingent
reporting: end-of-day IVR ratings of pain severity
do accurately reﬂect real-time reports provided
throughout that day [62]. This suggests that once-daily
IVR symptom reports are an accurate measure of
chronic pain progression.
IVR is also a useful tool for tracking changes in
symptom presentation over extended periods of
time [45, 74, 75]. IVR is especially useful in the
study of chronic pain because of its ability to
monitor not only pain severity, but also comorbid
symptoms such as depression, anxiety, and quality
and quantity of sleep [70, 76]. Many of the
emotional symptoms that present comorbidly with
chronic pain can be assessed by adapting established
questionnaires (e.g., the Hamilton Depression Rating
Scale [77]) for IVRuse. Examination of the relationship
between negative emotions (anger, sadness, and stress)
and pain variables using IVR has revealed signiﬁcant
correlations between emotion variables, pain severity,
and ability to control pain [60]. Because these relation-
ships exist, it is important that IVR systems that track
depressive systems be programmed to notify study
personnel if a subject reports an increased incidence of
dangerous thoughts or behaviors. Depending on
patient responses, follow-up interventions cannot only
be arranged when necessary, but also custom-tailored
for individual patients [78].
These ﬁndings are important because they pro-
vide insight into the relationships between negative
emotions and pain, and suggest that therapeutic
interventions for chronic pain might be effective in
reducing both pain severity and negative emotions.
The novel use of IVR to perform accurate symptom
monitoring may extend the gains of chronic pain
treatment by providing regular and/or real-time
assessments of the chronic pain progression and its
relationship to mood, stress, and coping. Taken one
step farther, IVR is also a useful tool for gauging the
efﬁcacy of ongoing treatments.
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IVR FOR ASSESSMENT OF TREATMENT EFFICACY
IN CHRONIC PAIN
As useful a tool as IVR is for monitoring symptom
status and pain progression under normal daily
circumstances, it is also a helpful tool for quantifying
the effectiveness of ongoing treatments for chronic
pain. IVR is utilized during pharmaceutical trials in
order to track pain symptoms, negative emotions
associated with pain, and adverse side effects of
speciﬁc medications [9, 79–81]. Some studies merely
examine symptoms and side effects longitudinally,
while others take advantage of IVR’s ability to
provide regular and/or real-time data in order to
examine time of pain onset, time for symptoms to
fade after medication administration, satisfaction
with pain control, and patterns of associated nega-
tive emotions and quality of sleep [82, 83]. Further,
examination of the relationships between symptom
progression, negative affect, type of therapeutic
approach, and the level of success of treatment
may offer insight into why some treatments work for
some patients but not others, or even assist with
deciding which treatment options to pursue for
speciﬁc patients.
The effectiveness of therapeutic interventions such
cognitive behavioral therapy and coping skills
training for treating chronic pain disorders has been
known for some time [73, 84–92]. More recently,
IVR has also been used as a follow-up to treatment
in order to assess the efﬁcacy of therapeutic
interventions. This data stresses the importance of
coping skills and control of catastrophizing to
successful treatment of chronic pain [93, 94].
Patients who received eight sessions of pain coping
skills training reported signiﬁcantly decreased levels
of pain severity and degree of catastrophizing
2 months after surgical intervention for pain [94].
IVR provides an easy and convenient way to track
these symptoms and quality-of-life concerns longi-
tudinally, both during and after the completion of
therapeutic intervention.
THERAPEUTIC IVR FOR EXTENDING TREATMENT GAINS
IN CHRONIC PAIN
Patient use of CBT skills over time tends to decline
once CBT has ceased, and treatment gains accom-
plished by CBT are not maintained if patients stop
using coping skills [44, 95–97]. If patients continue
to use and practice these skills, the therapeutic effect
is not only maintained but is augmented [44, 98].
The creation of automated IVR systems that not
only monitor symptoms, but also guide patients
through reminders and practice sessions of the
coping skills learned in CBT represent a convenient
and inexpensive method that may greatly contribute
to extending therapeutic treatment gains [44, 71].
The therapeutic interactive voice response (TIVR)
program developed by Naylor et al. is a telephone
interface that is capable of collecting data from
patients just as standard IVR systems do, but also
provides therapeutic beneﬁts that persist long past
the actual duration of psychotherapeutic interven-
tion [44, 71]. One experiment followed 11 weekly
90-min sessions of CBT with 4 months of daily
TIVR that utilized a relapse prevention model of
behavioral change [59, 99] to decrease pain severity
and improve coping. Many of the coping skills
that are taught to patients [59] with chronic
musculoskeletal pain as part of a CBT regimen
[85] can be easily converted into TIVR review
and practice sessions [44]. These coping skills
have been shown to be most successful when
practiced regularly outside of the clinical setting.
To extend therapeutic gains of group CBT, TIVR
has been effectively applied to the treatment of
chronic pain by reinforcing pain coping skills and
providing patients with educational support that
can be accessed on-demand.
This speciﬁc TIVR regimen consists of four
components: (1) automated access to self-monitoring
of symptoms, (2) didactic review sessions of coping
skills, (3) guided behavioral rehearsals of pain
management skills, and (4) personalized encourage-
ment and reinforcement. The relationship between
these four components of TIVR and their roles in
relapse prevention are outlined in Fig. 1.
Symptom self-monitoring is comprised of a daily
questionnaire to assess levels of pain, mood, and
stress, use of pain medications, and a variety of
other parameters. Didactic review sessions and
guided behavioral rehearsals are offered for eight
different coping skills learned previously during
group therapy such as relaxation techniques, cogni-
tive skills, activity–rest pacing, and reappraisal of
pain. This variety of coping techniques ensures that
patients are aware of multiple options for coping
with pain, an important part of the relapse preven-
tion model [59, 99]. The guided rehearsals not only
remind patients of their coping options but may also
enhance patients’ feelings of self-efﬁcacy in their
ability to deal with their pain. Self-efﬁcacy may
improve because TIVR promotes self-directed treat-
ment by allowing patients to be proactive and
monitor the relationships between continued use of
coping skills and improvement of pain-related
symptoms [44]. It has been suggested that IVR’s
ability to help patients set and achieve small,
realistic, and incremental goals may contribute to
increased self-efﬁcacy [100]. The ﬁnal component of
the TIVR approach (personalized encouragement)
consists of monthly messages for each patient
recorded by the CBT group therapist. These messages
contain a summary of the patient’s daily reports to the
TIVR system for the past month, insights into
possible relationships between reported pain,
negative emotions, and use of coping skills;
suggestions for pain management tactics; and
verbal encouragement. The treatment efﬁcacy
assessments for monthly messages can be easily
visualized by compiling the data into a longitudinal
chart of symptom progression (Fig. 2).
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The relapse prevention model suggests that this
regular monthly feedback, which simulates the
weekly feedback provided during the initial CBT
training, likely helps patients to gauge their progress
and recognize successes and problems in coping
with difﬁcult situations [101]. The personalized
monthly messages may also serve to further
strengthen patients’ sense of self-efﬁcacy.
After 4 months of TIVR, patients reported that
the method reinforced the skills that they learned
during face-to-face CBT, enhanced their motivation
to continue using coping skills, and provided
structure that helped the new skills become habits
[44, 71]. The data showed that patients who were
randomized to the TIVR program experienced
signiﬁcant improvements after both 4 and 8 months
of CBT as compared to baseline and to control
subjects who received CBT but did not participate in
TIVR [71]. TIVR subjects also reported decreased use
of opioid analgesics [59]. Considered together, these
Fig 1 | A relapse prevention model of coping with pain: this model depicts the interrelationships between chronic pain,
psychosocial stressors, therapy, and coping skills use for chronic pain. Adapted from F. Keefe by M. Naylor [59], reprinted
with permission
Fig 2 | Single subject daily TIVR data: an example of an IVR daily data chart depicting trends in and relationships between
pain, coping, and catastrophizing over a 4-month calling period (7-day moving averages). Currently, these charts are
utilized by the clinician to monitor patient symptom progression and create feedback messages. In the future, graphs like
this might also be sent to patients via email or smartphone applications for visual emphasis of treatment progress
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results strongly suggest that TIVR has the ability to
extend the treatment gains associated with CBT for
coping with chronic pain long after clinical visitations
have ceased.
FUTURE DIRECTIONS AND CONCLUSIONS
Since TIVR was ﬁrst demonstrated to be an
effective adjunct to therapy for chronic pain, a
similar system was employed to treat pain and other
symptoms in cancer patients [78]. In this study,
patients in both an “Automated Telephone Symp-
tom Management” group and a “Nurse-Assisted
Symptom Management” control group showed
clinically signiﬁcant improvements in symptom
severity. The authors suggested that these speciﬁc
patient responses could effectively be used to tailor
follow-up assessments and interventions to speciﬁc
patient needs. Another recent pilot study [41]
investigated the use of TIVR for relapse prevention
following CBT for alcohol use disorders. Automated
IVR “self-administered psychotherapy” has proven
to be an effective mediator of symptoms of depression
[40] and, while not speciﬁcally IVR-based, there is
evidence that self-administered and minimal-contact
therapies are also useful in treating anxiety [102]. In
combination with the ﬁndings regarding TIVR and
chronic pain, these results suggest that TIVRmight be
successfully applicable to treating a variety of other
medical conditions in addition to chronic pain.
Current research is being conducted to test the
hypothesis that TIVR without personalized monthly
messages from a therapist can be as effective as with
monthly messages. If conﬁrmed, the TIVR method
would become even more affordable to the general
public. Because some patients might beneﬁt from
using a more visual interface than that provided by
IVR, further investigation is required to determine
whether the effectiveness of TIVR could be further
improved by adaptation to an internet-based
approach. Such an approach could include pre-
recorded visual interactions with an actual or simulated
therapist, or even just written text presented simulta-
neously with pre-recorded messages/questions. It
would even be possible to incorporate video commu-
nication into this type of approach, allowing for both
automated and live interactions with a therapist.
Adaptation of TIVR to a smartphone application is
another possible next step for this emerging technology.
This would allow both the visual interactions that are
currently achievable via the internet as well as the
convenience of accessing the IVR system using a
portable, hand-held device.
Another possibility that merits further investiga-
tion is whether IVR as a therapeutic intervention is
effective enough to actually replace CBT for people
who cannot afford therapy or for whom CBT is
unavailable. Overall, IVR has so far proven to be an
effective, convenient, inexpensive, and reliable
method for monitoring symptom severity, tracking
treatment progress, and for extending the therapeutic
gains of clinical interventions for chronic pain. As
technology improves, and as more questionnaires,
surveys, and therapeutic interventions are adapted for
automated administration, IVR will likely play an
increasingly important role in both clinical research
and treatment regimens for patients with many
different psychological and physiological disorders.
We therefore recommend that IVR-based treatment
approaches be employed by multidisciplinary clinics
and practitioners who treat patients with chronic
pain. Further, as IVR-based interventions are
clinically beneﬁcial, versatile, and cost-effective;
we advise that policymakers endorse insurance
coverage of IVR for pain management as part of
comprehensive treatment plans.
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